adalimumab (preferred products) — Highmark
Psoriatic Arthritis (PsA) - spinal or axial
Initial criteria
- age ≥ 18 years
- diagnosis of spinal or axial PsA
- prescribed by or in consultation with a rheumatologist or dermatologist
- experienced therapeutic failure or intolerance to at least one NSAID OR all NSAIDs are contraindicated
Reauthorization criteria
- member has demonstrated disease stability or a beneficial response to therapy